The high expression of GCSH (γ-glutamylcysteine synthetase) has been confirmed to be associated with poor prognosis in endometrial cancer (Zhao et al., 2024) and cholangiocarcinoma (He et al., 2024) patients. The gene discussed is GCSH; the disease is endometrial cancer.